首页> 美国卫生研究院文献>BMC Biotechnology >Detection of distinct glycosylation patterns on human γ-glutamyl transpeptidase 1 using antibody-lectin sandwich array (ALSA) technology
【2h】

Detection of distinct glycosylation patterns on human γ-glutamyl transpeptidase 1 using antibody-lectin sandwich array (ALSA) technology

机译:使用抗体-凝集素三明治阵列(ALSA)技术检测人γ-谷氨酰转肽酶1上不同的糖基化模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Backgroundγ-Glutamyl transpeptidase 1 (GGT1) is an N-glycosylated membrane protein that catabolizes extracellular glutathione and other γ-glutamyl-containing substrates. In a variety of disease states, including tumor formation, the enzyme is shed from the surface of the cell and can be detected in serum. The structures of the N-glycans on human GGT1 (hGGT1) have been shown to be tissue-specific. Tumor-specific changes in the glycans have also been observed, suggesting that the N-glycans on hGGT1 would be an important biomarker for detecting tumors and monitoring their progression during treatment. However, the large quantities of purified protein required to fully characterize the carbohydrate content poses a significant challenge for biomarker development. Herein, we investigated a new antibody-lectin sandwich array (ALSA) platform to determine whether this microanalytical technique could be applied to the characterization of N-glycan content of hGGT1 in complex biological samples.
机译:背景γ-谷氨酰转肽酶1(GGT1)是N-糖基化膜蛋白,可分解代谢细胞外谷胱甘肽和其他含γ-谷氨酰的底物。在包括肿瘤形成在内的多种疾病状态下,酶从细胞表面脱落,可以在血清中检测到。已显示人GGT1(hGGT1)上N聚糖的结构具有组织特异性。还观察到了聚糖中的肿瘤特异性变化,这表明hGGT1上的N-聚糖将是检测肿瘤并监测治疗过程中肿瘤进展的重要生物标志物。然而,充分表征碳水化合物含量所需的大量纯化蛋白对生物标志物的开发提出了重大挑战。在本文中,我们研究了一种新的抗体-凝集素三明治阵列(ALSA)平台,以确定这种微分析技术是否可用于表征复杂生物样品中hGGT1的N-聚糖含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号